Today, we're thrilled to announce the Tapestri Single-cell Multiple Myeloma Multiomics Solution! 🎉 This groundbreaking product suite is set to transform MM research and therapeutic development, offering unparalleled insights into disease evolution and biology at the single-cell level. 🔬 Our new solution integrates genomic, proteomic, and clonotypic assessments in a single assay, providing comprehensive clonal and subclonal insights that surpass existing bulk methodologies. This will empower researchers and drug developers to fully dissect the molecular and cellular landscape of myeloid progression, understand therapy resistance, and address disease relapse more effectively. Stay tuned for more details, including late-breaking data to be presented at the European Hematology Association (EHA) Congress on June 14. 📅 Check out our press release to learn more https://bit.ly/4e9AEtE #multiplemyeloma #singlecell #multiomics #pressrelease #eha2024
Mission Bio
Biotechnology Research
South San Francisco, California 18,373 followers
The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution.
About us
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. In 2014, the company was spun out of Adam Abate’s lab for high-throughput biology at the University of California, San Francisco (UCSF). Mission Bio’s precision genomics platform is based on the pioneering droplet microfluidics work of Abate and his team. Our mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine. Visit missionbio.com to learn more.
- Website
-
http://www.missionbio.com
External link for Mission Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Genomics, Single-cell analysis, Precision Medicine, Precision Genomics, Bioinformatics Support, DNA Analysis, and Droplet Microfluidics
Locations
-
Primary
Get directions
400 E Jamie Ct
Suite 100
South San Francisco, California 94080, US
Employees at Mission Bio
Updates
-
We're thrilled to announce the Tapestri Genome Integrity CNV Solution is now available! This powerful solution unlocks numerous applications in therapeutic development and oncology research: 🚀 Combine Gene Editing & Genome Integrity Analysis: Enhance CRISPR-edited cell safety profiling with a multi-attribute approach. 🚀 Assess Stem Cells Post-Reprogramming or Differentiation: Detect genomic aberrations with improved throughput. 🚀 Evaluate Clonal and Subclonal Heterogeneity: Gain insights into CNV linked to tumor evolution and therapeutic resistance immune evasion. 🚀 Correlate Multiomic Data: Combine CNV, SNV, and surface immunophenotypic measurements at single-cell resolution. Learn more about how you can empower your research here 👉 https://lnkd.in/gzy4whn7
-
-
Mission Bio is always on the go 🏃♂️ 🏃♀️ Last week our experts Azad Gucwa, Ph.D., MT(ASCP) and Erik Marchese MS, MBA visited Winship Cancer Institute of Emory University to discuss our single-cell Multiple Myeloma Multiomics Solution and scMRD Assay for AML. Learn more here 👉 https://missionbio.com/
Senior Field Application Scientist & Educator | Single-cell Multi-omics | I am passionate about sharing my love of science with others 👩🏻🔬
Erik Marchese MS, MBA and I had a great time at the Winship Cancer Institute of Emory University last week! We had some great discussions on how Mission Bio's Single-cell Multi-omics MRD (scMRD) Assay for AML and Multiple Myeloma multi-omics solution may be used to help guide clinical trials and the important work being done there. Many thanks to Janghee Woo MD PhD, for his continuous support and allowing us to come for a visit!
-
-
We're excited to be attending the hubXchange Advanced Therapies Xchange in San Francisco this week! If you're attending, be sure to catch Nori U. there - he'll be presenting on utilizing single-cell analysis for measuring genotoxicity arising from gene editing experiments. Get all the info here 👉 https://lnkd.in/drwdWwX9
-
Join our livestream today at DKFZ German Cancer Research Center where our invited speakers will present data from different areas of research like AML, single-cell MRD in AML, functional phenotyping of genomic variants using multiomic scDNA-scRNA-seq, targeted single-cell DNA methylation, and genome editing. Join us now ➡ https://lnkd.in/gfAXbVz8
Welcome! You are invited to join a webinar: DKFZ Seminar Livestream. After registering, you will receive a confirmation email about joining the webinar.
missionbio.zoom.us
-
Mission Bio is on the move! 🏃♂️ 🏃♀️ Be sure to catch our experts Shawn Clouthier and Yvette Halley-Schultz next week at University of Minnesota in Minneapolis! They'll be discussing heterogeneity in clonal hematopoesis, proteogenomics of liquid and solid tumors, AML and MM MRD, and our latest gene editing applications. 📅 Reach out to Shawn or Yvette to book some office hours or to learn more!
Today, we're thrilled to announce the Tapestri Single-cell Multiple Myeloma Multiomics Solution! 🎉 This groundbreaking product suite is set to transform MM research and therapeutic development, offering unparalleled insights into disease evolution and biology at the single-cell level. 🔬 Our new solution integrates genomic, proteomic, and clonotypic assessments in a single assay, providing comprehensive clonal and subclonal insights that surpass existing bulk methodologies. This will empower researchers and drug developers to fully dissect the molecular and cellular landscape of myeloid progression, understand therapy resistance, and address disease relapse more effectively. Stay tuned for more details, including late-breaking data to be presented at the European Hematology Association (EHA) Congress on June 14. 📅 Check out our press release to learn more https://bit.ly/4e9AEtE #multiplemyeloma #singlecell #multiomics #pressrelease #eha2024
-
-
📣 Join us TOMORROW, Thursday, September 12, for Part 2 of our Getting Started with Single-cell DNA Sequencing series, which is all about our in-house assay development services! Our experts Holly Baden-Tillson and Andrew Reitinger will be discussing our Pharma Assay Development (PAD) program, including: 🧬 Overview of PAD services: end-to-end custom assay service and support for biomarker discovery and therapeutic development 👩🔬 Applications enabled by PAD 🔬 Cohort analysis for therapeutic development and insight 📊 Processes and milestones: from intake to fully analyzed reports Register here ➡ https://lnkd.in/gEqYk2sg
Welcome! You are invited to join a webinar: Part 2 Getting Started with Single-cell DNA Sequencing Series: Assay Development and Transfer. After registering, you will receive a confirmation email about joining the webinar.
missionbio.zoom.us
-
CRISPR preclinical models are becoming increasingly attractive because of the vast opportunities to study multiple genetic drivers of disease. In this article in Genetic Engineering & Biotechnology News, our own Vanee Pho explores the opportunities and challenges of CRISPR gene editing, and explains how single-cell multiomics can help researchers overcome the challenges of heterogeneous editing outcomes. https://lnkd.in/gYKsDREr
Validating CRISPR Preclinical Models with Multiomics
genengnews.com
-
❗ One week left to register❗ Join us Thursday, September 12 for Part 2 of our Getting Started with Single-cell DNA Sequencing series, which is all about our in-house assay development services! Our experts Holly Baden-Tillson and Andrew Reitinger will be discussing our Pharma Assay Development (PAD) program, including: 🧬 Overview of PAD services: end-to-end custom assay service and support for biomarker discovery and therapeutic development 👩🔬 Applications enabled by PAD 🔬 Cohort analysis for therapeutic development and insight 📊 Processes and milestones: from intake to fully analyzed reports Register right now to save your spot ➡ https://lnkd.in/gMR3-DAF
Welcome! You are invited to join a webinar: Part 2 Getting Started with Single-cell DNA Sequencing Series: Assay Development and Transfer. After registering, you will receive a confirmation email about joining the webinar.
missionbio.zoom.us
-
Azad Gucwa, Ph.D., MT(ASCP)'s talk is today. If you're World CDx in BOS, stop by. If not, but would like a copy of her presentation, let me know!
The World CB & CDx Summit in Boston is off to a great start! Swing by Booth 22 to visit our team and say hello! 👋 And be sure to catch Azad Gucwa, Ph.D., MT(ASCP) tomorrow at 2:20p ET, she'll be presenting on: ✅ Leveraging single-cell multi-modal analysis to get a more comprehensive view of multiple myeloma disease progression, therapy response and resistance, and therapy safety & efficacy ✅ Integrating SNVs, zygosity, CNVs, VDJ clonotype, and surface immunophenotype at the single-cell level, while measuring the transduction efficiency and vector copy number of potential CAR-T therapies ✅ Assessing genome integrity through genome-wide CNV analysis at the single-cell level and leverage cohort-level analysis to guide therapeutic and clinical development
-